Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? There are many different medical cannabis products. .

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.” SCHOOL-USE.

Law 262

Law Patients Access Oil 262

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. So just on safety alone, it’s worth using it. I include pharmaceutical drugs in that category. In general, I think that botanical medicine is safer than pharmaceutical medicine.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. Caffeine can also be found in pharmaceutical 33 and non-pharmaceutical products.)

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. The industry also encourages the development of novel pharmaceuticals and treatments, creating opportunities for Maryland residents to access cutting-edge healthcare options.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Enquiries: GW Pharmaceuticals plc.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Canna Law Blog

FEBRUARY 25, 2022

If you keep a pulse on this issue, you know that for the past three years, the FDA has held the position that CBD cannot be marketed as a dietary ingredient because it was first studied and approved as a drug ingredient in GW Pharmaceuticals’ Epidiolex ( Drug Exclusion Rule ). According to NPA’s petition, the U.S.

CBD 82

CBD Data Safety Food 82

Cannabis Law Report

FEBRUARY 1, 2022

Medical cannabis and psychedelics are being increasingly recognised by health professionals for their superior safety and efficacy compared to conventional pharmaceuticals. Due to its illegality and stigma, patients greatly suffered from an inability to access this medicine.

Pharmaceutical 52

Pharmaceutical Medicine Safety Epilepsy 52

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? NH resident? OK resident?

Legislation 243

Legislation Patients Decriminalization Access 243

Veriheal

SEPTEMBER 7, 2022

’s medical cannabis program come on the heels of a previously enacted emergency amendment focused on senior citizens: The Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 allowed D.C. The State of Patients’ Rights and Access in America Today. These changes to D.C.’s

Patients 97

Patients Programs Access Treatment 97

Cannabis Cheri

JANUARY 3, 2019

As a consequence, the FDA has required pharmaceutical companies to drop the word “may” and make it clear on their warning labels that “NSAIDs cause an increased risk of serious heart thrombotic events, including myocardial infarction and stroke, which can be fatal. Now many will be.

Research and Development 190

Research and Development Safety Cannabis Access 190

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

MMJ Recs

APRIL 1, 2024

Its non-addictive nature and minimal side effects make it an attractive alternative to conventional pharmaceuticals for many individuals seeking natural remedies. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

Veriheal

AUGUST 9, 2023

Although CBD’s full medical benefits and safety profile are still under review by researchers and appropriate regulators, the compound has successfully scaled several legal roadblocks. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 93

CBD Cannabinoids THC Extraction 93

Canna Law Blog

JULY 4, 2019

The opening paragraph of the statement is reassuring: Science forms the basis for decisions at the [FDA] and is paramount when it comes to making decisions that will impact the health and safety of the American public. The problem is that people may not trust the FDA with something as popular as public access to CBD oil.

CBD 83

CBD Hemp Oil Safety 83

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Cannabis Law Report

JULY 28, 2021

This agreement will provide access to Evotec’s technology platform to further accelerate the development of OCT461201 towards phase 1 clinical trials aimed at demonstrating its safety and tolerability by utilising its “INDiGO” programme, an integrated drug development process for expediting early drug candidates to the clinical trial stage.

Cannabinoids 105

Cannabinoids Clinical Trials Safety Medicine 105

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. In Virginia, these families were simply asking to be able to possess the medicines they were able to access in other states. This interview has been edited for clarity and space. We need to do more.

Marijuana 217

Marijuana Legalization Programs Oil 217

Cannabis Law Report

JANUARY 10, 2020

Being a member of the Drug Science Medical Cannabis Working Group, Schlag’s current research focuses on the controversies surrounding medical cannabis and the application of MultiCriteria-Decision-Analysis to assess benefits and safety. Deepak Anand. Deepak Anand is recognised as a thought leader in the global cannabis space.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

Cannabis Law Report

JANUARY 3, 2022

CBD Product Safety and Standardization Act of 2021. The most recent legislation to debut on behalf of hemp, the CBD Product Safety and Standardization Act of 2021, was introduced this month by a bipartisan group of U.S. Hemp Access and Consumer Safety Act. representatives, including Reps. Hemp champion Sen.

Hemp 52

Hemp Packaging Banking Food 52

NORML

JANUARY 25, 2019

179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. Legislation is pending, House Bill 1150, to expand the state’s nascent medical cannabis access law. HI resident? IA resident? MO resident? North Dakota. NH resident?

Legislation 154

Legislation Patients Oil Hemp 154

Cannabis Cheri

JANUARY 3, 2019

As a consequence, the FDA has required pharmaceutical companies to drop the word “may” and make it clear on their warning labels that “NSAIDs cause an increased risk of serious heart thrombotic events, including myocardial infarction and stroke, which can be fatal. Now many will be.

Research and Development 100

Research and Development Safety Access Cannabis 100

Cannabis Law Report

JANUARY 19, 2022

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. Waldhausklinik is a non-profit acute care hospital for internal medicine in the Free State of Bavaria and has entered into a research collaboration with AMP into the efficacy and safety of medical cannabis.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Several veteran’s groups advocate for greater access to medical marijuana. Current Issues in Marijuana Regulation. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

Cannabis Law Report

JULY 19, 2021

We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials. Extensive early phase experience with appropriate safety oversight and early phase clinic.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

NOVEMBER 3, 2021

In parallel, we are working to make our extracts for inhalation accessible to patients in other countries on the continent as well as to register them in the appropriate regulatory tracks.”. Going forward, our collaboration with Panaxia will allow us to further develop our product offering and provide medical cannabis to promising markets.”.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans.

Safety 52

Safety Research and Development Compliance Compliance 52

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. Pain intensity and safety parameters were recorded on a 10-cm visual analogue scale (VAS) at pre-defined time points.

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” ” State Doctors Oppose Legalization in Alabama.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 90

Therapy Legalization Chronic Pain DEA 90